Fierce Pharma
SEPTEMBER 27, 2024
In the latest of several recent mpox vaccine supply deals, Bavarian Nordic plans to provide 1 million doses of its shot, Jynneos, to affected African countries through an agreement with UNICEF. | The agreement is the latest in a string of mpox vaccine supply deals that have come in response to the ongoing outbreak in Africa.
MedCity News
SEPTEMBER 27, 2024
The new generation of healthcare AI innovation is promising, but there are some problems that remain when it comes to AI, such as data generalization and the high cost of adopting new tools, pointed out Dr. Arash Harzand. The post AI Holds Promise, But Concerns Around Costs and Data Remain appeared first on MedCity News.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Fierce Pharma
SEPTEMBER 27, 2024
Shortly after winning full FDA approval for its rare kidney disease drug Filspari, San Diego’s Travere Therapeutics has run into trouble with its enzyme replacement candidate pegtibatinase. | Travere is pausing enrollment in its Harmony study evaluating pegtibatinase in classic homocystinuria to make improvements on manufacturing scale-up for commercial production and to fully enroll the phase 3 trial.
MedCity News
SEPTEMBER 27, 2024
Bristol Myers Squibb’s Cobenfy treats schizophrenia by going after a different target than currently available antipsychotic drugs, which is intended to offer better efficacy and safety. The drug came from the pharma giant’s $14 billion acquisition of Karuna Therapeutics. The post FDA Approval of Bristol Myers Drug Makes It the First Novel Schizophrenia Med in Decades appeared first on MedCity News.
Advertisement
What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.
Fierce Pharma
SEPTEMBER 27, 2024
AstraZeneca and Daiichi Sankyo's Dato-DXd failed to improve survival in a breast cancer study. Gilead Sciences' Kite will bow out of its China joint venture with Fosun Pharma. | AstraZeneca and Daiichi Sankyo's Dato-DXd failed to improve survival in a breast cancer study. Gilead's Kite will bow out of its China joint venture with Fosun Pharma.
MedCity News
SEPTEMBER 27, 2024
Artificial intelligence (AI) holds potential to forecast and predict where hospital leaders should direct limited resources such as clinicians, staff, and beds to improve operational efficiency and drive better patient outcomes. The post How AI Can Help Hospitals Overcome Patient Flow Barriers appeared first on MedCity News.
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
pharmaphorum
SEPTEMBER 27, 2024
World leaders seek 10% cut in antibiotic resistance deaths Phil.
Fierce Pharma
SEPTEMBER 27, 2024
Patients with rare or complex diseases often struggle to find specialists who meet their specific condition and individual needs. | Patients with rare or complex diseases struggle to find specialists who fit their unique needs, delaying crucial care. Digital tools can help.
MedCity News
SEPTEMBER 27, 2024
Pomelo Care recently acquired The Doula Network. Through the acquisition, Pomelo’s patients can now be matched with a community-based doula. The post Pomelo Care Acquires The Doula Network to Link Patients with Community-Based Doulas appeared first on MedCity News.
pharmaphorum
SEPTEMBER 27, 2024
Cassava Sciences will pay $40m to settle SEC charges that it made misleading claims about a phase 2b study of Alzheimer's candidate simufilam.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
MedCity News
SEPTEMBER 27, 2024
Precision medicine relies on understanding how differences affect drug response. Researchers can develop more precise treatments that are effective for more patients when prioritizing diversity. The post Why Accessible, Worldwide Biomanufacturing Solutions are Paramount appeared first on MedCity News.
pharmaphorum
SEPTEMBER 27, 2024
Sanofi's Dupixent scores double COPD win in US, China Jonah.
Pharmaceutical Technology
SEPTEMBER 27, 2024
Bavarian Nordic has already said it would prioritise mpox vaccine production to fulfil orders this year.
pharmaphorum
SEPTEMBER 27, 2024
BMS' acquisition of Karuna looks set to pay off after it gets FDA approval for the schizophrenia drug at the heart of the $14bn takeover
Advertisement
Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten
European Pharmaceutical Review
SEPTEMBER 27, 2024
The US Food and Drug Administration (FDA) has approved Cobenfy (xanomeline and trospium chloride) for schizophrenia in adults. “Today’s landmark approval of our first-in-class treatment for schizophrenia marks an important milestone for the community, where after more than 30 years, there is now an entirely new pharmacological approach for schizophrenia — one that has the potential to change the treatment paradigm,” shared Dr Chris Boerner , PhD, Board Chair and Chief Executive Officer at Bristo
Pharmaceutical Technology
SEPTEMBER 27, 2024
The FDA has approved the first treatment for schizophrenia that targets cholinergic receptors rather than dopamine receptors.
pharmaphorum
SEPTEMBER 27, 2024
NICE backs Roche's PiaSky for NHS treatment of paroxysmal nocturnal haemoglobinuria, the first drug that can be self-administered by patients.
Pharmaceutical Technology
SEPTEMBER 27, 2024
Biocon has entered a partnership with Tabuk for the commercialisation of glucagon-like peptide-1 (GLP-1) products in the Middle East.
PharmaTech
SEPTEMBER 27, 2024
The new mechanism of action targets cholinergic receptors instead of the standard dopamine receptors.
Pharmaceutical Technology
SEPTEMBER 27, 2024
The US Food and Drug Administration (FDA) has announced the approval of Sanofi and Regeneron’s interleukin (IL)-4 and IL-13 monoclonal antibody, Dupixent, for the US market.
PharmaTech
SEPTEMBER 27, 2024
The agency is recommending that the market authorization for Oxbryta (voxelotor) be suspended so that emerging data may be reviewed.
Eversana Intouch
SEPTEMBER 27, 2024
Gurdip Daffu, VP, Medical Strategy; Anne Marie Robertson, EVP, EVERSANA ONCOLOGY Commercialization™; Vanitha Sankaran, VP, Medical Strategy; Barry Vucsko, SVP, Strategic Development Every year, the European Society for Medical Oncology (ESMO) brings together experts from pharma, research and advocacy organizations, and healthcare providers (HCPs) to hear about the year’s biggest oncology breakthroughs.
Advertisement
Quotas need to be hit. Revenue goals need to be met. This reality makes shortening sales onboarding time a top priority. Organizations with a standard onboarding process boost employee retention by 58% and increase productivity by 50%. Unfortunately, many companies struggle with inefficient processes that lead to high turnover and missed revenue opportunities.
Pharmaceutical Technology
SEPTEMBER 27, 2024
Tempus AI has announced an expanded collaboration with Takeda to enhance oncology research and development.
Pharmacy Times
SEPTEMBER 27, 2024
Dupilumab is the first biologic medicine for patients with chronic obstructive pulmonary disease to be approved in the US.
Pharmaceutical Technology
SEPTEMBER 27, 2024
Customised medication providers come under scrutiny as weight management copycat drugs raise safety concerns.
Pharmacy Times
SEPTEMBER 27, 2024
Xanomeline and trospium chloride is the first in a new class, offering a new approach with selectively targeting M 1 and M 2 receptors.
Rep-Lite
SEPTEMBER 27, 2024
Success in the medical sales industry hinges on a company’s ability to consistently meet or exceed sales targets. Medical sales representatives are at the forefront of driving this success by engaging with healthcare providers, understanding their needs, and delivering solutions that meet clinical and patient outcomes. However, many teams face challenges in achieving these goals, leading to unmet expectations, missed revenue targets, and the constant question, “Why is my team failing to me
Pharmacy Times
SEPTEMBER 27, 2024
Study results showed that Black women with breast cancer were more likely to die across all subtypes, with the disparity varying from 17% to 50% depending on subtype.
Pharma Marketing Network
SEPTEMBER 27, 2024
In recent years, the pharmaceutical industry has increasingly embraced digital transformation, and one of the most impactful areas of this change is in marketing. Programmatic advertising, which involves the automated buying and selling of online ads, has become a cornerstone of modern marketing strategies. By leveraging vast amounts of data, programmatic advertising allows for more precise targeting and personalized messaging than traditional methods.
Pharmacy Times
SEPTEMBER 27, 2024
The work of Obstetrician Ignaz Semmelweis lives on in medical protocols today.
Advertisement
Are your sellers unsure about using AI in their day-to-day workflows? Or are they eager to try but uncertain where to start? They might be asking: Which tasks are best suited for AI? How will using AI affect my relationship with my customers? With so many tools available, which ones are the most useful to me? To help answer these and other common questions about using AI during the sales cycle, we surveyed B2B sellers who were early adopters to get their insight and advice about how to use gen A
Expert insights. Personalized for you.
278 
Let's personalize your content